NEW YORK (GenomeWeb News) – Shares of molecular diagnostics firm Nanosphere fell more than 35 percent on Monday, though there was no news or regulatory filings that would account for such a sell off.

The Dow Jones Industrial Average closed down .4 percent, and almost all of the firms in the GenomeWeb Daily News Index finished in negative territory for the day.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.